La sífilis continúa representando una creciente amenaza para la salud pública en las Américas. En los últimos años, múltiples países han reportado aumentos sostenidos en sífilis adquirida, sífilis ...
Tuberculosis (TB) continues to be one of the leading causes of disease and death from infectious disease in the Region of the Americas, particularly among people living with HIV. In 2024, it was es...
A tuberculose (TB) continua sendo uma das principais causas de adoecimento e morte por doenças infecciosas na Região das Américas, particularmente entre as pessoas que vivem com HIV. Em 2024, estim...
La tuberculosis (TB) continúa siendo una de las principales causas de enfermedad y muerte por enfermedad infecciosa en la Región de las Américas, particularmente entre las personas que viven con el...
Let's Take the Shot and End Pediatric AIDS ⚽️
A lot can happen in four years. Kids grow up. Teams get stronger. Diseases are eradicated.
When the world gathers around the pitch again in 2030, it could be in a world where no child is born with ...
The next era of the global HIV prevention response must be community-led, free of stigma, and stripped of systemic barriers.
Addressing the High-Level Meeting on HIV/AIDS, UNFPA Executive Director...
🔴 Gaza, ébola y VIH. Tres noticias, un mismo recordatorio: con la salud no se juega.
❤️🩹 Nuestro informativo humanitario fue grabado antes del terremoto en Venezuela. Nuestros pensamientos y soli.
LIVE: Media briefing on #Ebola and global health issues with Dr Tedros
LIVE: Media briefing on #Ebola and global health issues with Dr Tedros
HIV prevention should not be a privilege
MSF International President Dr. Javid Abdelmoneim explains our call for Gilead to make lenacapavir more accessible to those who need it.
Visit our website: http://www.msf.org.au
Donate: http://www...
Press Conference by Winnie Byanyima, Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS) on the General Assembly High-Level Meeting on HIV/AIDS.
The fifth meeting since t...
Lenacapavir: A gamechanger in HIV prevention, but out of reach
Lenacapavir, or LEN, is a gamechanging HIV prevention injection given just twice a year and shown to be nearly 100% effective.
But Gilead is keeping LEN out of reach for many people in low- and mi...
Nisha*, 31, lives with her two daughters and extended family. Her journey with HIV has been marked by illness, fear, and uncertainty but also by resilience and hope. After months of severe symptoms...
A game‑changer in HIV prevention has arrived: lenacapavir (LEN). With up to 100% effectiveness and just two doses a year, LEN has the potential to transform HIV prevention, especially for key and v...
HIV prevention should not be a privilege
MSF International President Dr. Javid Abdelmoneim explains that a drug exists that is nearly 100 percent effective at preventing HIV and only needs to be taken twice a year. It's called lenacapavir...
Bate Papo na Saúde – Ciência, SUS e Sociedade Civil de Mãos Dadas na Luta Contra Aids: Esta edição do Bate Papo na Saúde fala sobre Ciência, SUS e Sociedade Civil de Mãos Dadas na Luta Contra Aids....
Day of the African Child with EGPAF
Today is the Day of the African Child!
When we reach the children of Sub-Saharan Africa, when no child is born with HIV, when every child who needs treatment gets treatment, that is how we get to ...
O conhecimento sobre o seu status sorológico é um passo fundamental para o autocuidado.
🩺 Com o autoteste de HIV, você tem a liberdade e a privacidade de realizar a testagem quando se sentir mais ..
This is what we do at EGPAF
It’s actually pretty simple. We help families live healthy, AIDS-free lives.
#endaids #generationzerohiv